First-in-class antispastic drug candidate to reach clinical phase is published in the prestigious life science journal, Cell. Drug candidate MPH-220 could mean new hope for millions of patients ...

Spasticity creates chronic muscle tightness and stiffness, which reduces overall mobility. If left unmanaged, spasticity may lead to complications, such as pain and frozen joints. Treatment for ...

Many of us have felt a muscle in some part of our body suddenly and involuntarily tighten, causing a twitch or even severe cramp. Muscle spasms are common and typically don't signal a severe health ...

Just 3 disease-modifying treatments—edaravone, riluzole, and sodium phenylbutyrate and taurursodiol (PB/TURSO)—are currently FDA approved to slow progression of amyotrophic lateral sclerosis (ALS). A ...

Symptoms of spasticity — including chronic muscle stiffness, pain, and jerkiness of voluntary movements — can interfere with your daily activities. Left untreated, these symptoms may significantly ...

There are two classes of muscle relaxers. Antispasmodics reduce spasms by inhibiting signals in the brain, while antispastics affect the spinal cord and reduce muscle tightness and spasms. While ...

Add Yahoo as a preferred source to see more of our stories on Google. To combat the surge, some doctors are choosing to prescribe muscle relaxers in place of opioids because they pose fewer risks and ...